Grace Ngiam

Grace holds a Bachelor of Biomedical Science (Honours) and contributed as a co-author to a journal publication on investigating cholinergic neuronal loss in Alzheimer's disease. She brings 2.5 years of experience in coordinating over 20 clinical research studies in cardiology, including first-in-human device trials, structural studies, phase III pharmacology research, and registry clinical trials.

Grace has a strong understanding of clinical research and regulatory compliance with ICH-GCP, ensuring the effective execution of trial-related activities such as study start-up, patient recruitment, ongoing monitoring, and close-out. Passionate about clinical research, Grace is committed to advancing medicine and improving patients' lives, particularly through her work with the QCGC team.